Literature DB >> 19164149

Amiodarone destabilizes intracellular Ca2+ homeostasis and biosynthesis of sterols in Leishmania mexicana.

Xenón Serrano-Martín1, Yael García-Marchan, Alexis Fernandez, Noris Rodriguez, Hector Rojas, Gonzalo Visbal, Gustavo Benaim.   

Abstract

Leishmaniasis represents a serious public health problem worldwide. The first line of treatment is based on glucantime and pentostan, which generate toxic effects in treated patients. We have recently shown that amiodarone, frequently used as an antiarrhythmic, possesses activity against Trypanosoma cruzi through the disruption of mitochondrial Ca(2+) homeostasis and the inhibition of parasite ergosterol biosynthesis, specifically at the level of oxidosqualene cyclase activity (G. Benaim, J. Sanders, Y. Garcia-Marchan, C. Colina, R. Lira, A. Caldera, G. Payares, C. Sanoja, J. Burgos, A. Leon-Rossell, J. Concepcion, A. Schijman, M. Levin, E. Oldfield, and J. Urbina, J. Med. Chem. 49:892-899, 2006). Here we show that at therapeutic concentrations, amiodarone has a profound effect on the viability of Leishmania mexicana promastigotes. Additionally, its effect on the viability of the parasite was greater against intracellular amastigotes than against promastigotes, and it did not affect the host cell. Using fluorimetric and confocal microscopy techniques, we also demonstrated that the mechanism of action of amiodarone was related to the disruption of intracellular Ca(2+) homeostasis through a direct action not only on the mitochondria but also on the acidocalcisomes. On the other hand, analysis of the free sterols in promastigotes incubated with amiodarone showed that this drug also affected the biosynthesis of 5-dehydroepisterol, which results in squalene accumulation, thus suggesting that amiodarone inhibits the squalene epoxidase activity of the parasite. Taken together, the results obtained in the present work point to a more general effect of amiodarone in trypanosomatids, opening potential therapeutic possibilities for this infectious disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19164149      PMCID: PMC2663059          DOI: 10.1128/AAC.01215-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  32 in total

Review 1.  Specific chemotherapy of Chagas disease: controversies and advances.

Authors:  Julio A Urbina; Roberto Docampo
Journal:  Trends Parasitol       Date:  2003-11

2.  Characterization of a novel, broad-based fungicidal activity for the antiarrhythmic drug amiodarone.

Authors:  William E Courchesne
Journal:  J Pharmacol Exp Ther       Date:  2002-01       Impact factor: 4.030

3.  Ultrastructural and biochemical alterations induced by 22,26-azasterol, a delta(24(25))-sterol methyltransferase inhibitor, on promastigote and amastigote forms of Leishmania amazonensis.

Authors:  Juliany C F Rodrigues; Márcia Attias; Carlos Rodriguez; Julio A Urbina; Wanderley de Souza
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

Review 4.  Leishmaniasis.

Authors:  B L Herwaldt
Journal:  Lancet       Date:  1999-10-02       Impact factor: 79.321

Review 5.  Recent advances in antileishmanial drug development.

Authors:  Antony J Davis; Lukasz Kedzierski
Journal:  Curr Opin Investig Drugs       Date:  2005-02

6.  Intracellular Ca2+ storage in acidocalcisomes of Trypanosoma cruzi.

Authors:  R Docampo; D A Scott; A E Vercesi; S N Moreno
Journal:  Biochem J       Date:  1995-09-15       Impact factor: 3.857

7.  Acidocalcisomes and the contractile vacuole complex are involved in osmoregulation in Trypanosoma cruzi.

Authors:  Peter Rohloff; Andrea Montalvetti; Roberto Docampo
Journal:  J Biol Chem       Date:  2004-10-04       Impact factor: 5.157

8.  Ca2+ transport by coupled Trypanosoma cruzi mitochondria in situ.

Authors:  R Docampo; A E Vercesi
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

9.  Ca2+ transport in isolated mitochondrial vesicles from Leishmania braziliensis promastigotes.

Authors:  G Benaim; R Bermudez; J A Urbina
Journal:  Mol Biochem Parasitol       Date:  1990-02       Impact factor: 1.759

10.  Anti-VSG antibodies induce an increase in Trypanosoma evansi intracellular Ca2+ concentration.

Authors:  M Mendoza; G L Uzcanga; R Pacheco; H Rojas; L M Carrasquel; Y García-Marchan; X Serrano-Martín; G Benaím; J Bubis; A Mijares
Journal:  Parasitology       Date:  2008-08-28       Impact factor: 3.234

View more
  28 in total

1.  Amiodarone inhibits Trypanosoma cruzi infection and promotes cardiac cell recovery with gap junction and cytoskeleton reassembly in vitro.

Authors:  Daniel Adesse; Eduardo Meirelles Azzam; Maria de Nazareth L Meirelles; Julio A Urbina; Luciana R Garzoni
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

Review 2.  Gap junctions and chagas disease.

Authors:  Daniel Adesse; Regina Coeli Goldenberg; Fabio S Fortes; Dumitru A Iacobas; Sanda Iacobas; Antonio Carlos Campos de Carvalho; Maria de Narareth Meirelles; Huan Huang; Milena B Soares; Herbert B Tanowitz; Luciana Ribeiro Garzoni; David C Spray
Journal:  Adv Parasitol       Date:  2011       Impact factor: 3.870

3.  SQ109, a new drug lead for Chagas disease.

Authors:  Phercyles Veiga-Santos; Kai Li; Lilianne Lameira; Tecia Maria Ulisses de Carvalho; Guozhong Huang; Melina Galizzi; Na Shang; Qian Li; Dolores Gonzalez-Pacanowska; Vanessa Hernandez-Rodriguez; Gustavo Benaim; Rey-Ting Guo; Julio A Urbina; Roberto Docampo; Wanderley de Souza; Eric Oldfield
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

4.  In vitro anti-Trypanosoma cruzi activity of dronedarone, a novel amiodarone derivative with an improved safety profile.

Authors:  Gustavo Benaim; Vanessa Hernandez-Rodriguez; Sheira Mujica-Gonzalez; Lourdes Plaza-Rojas; May Li Silva; Nereida Parra-Gimenez; Yael Garcia-Marchan; Alberto Paniz-Mondolfi; Graciela Uzcanga
Journal:  Antimicrob Agents Chemother       Date:  2012-04-16       Impact factor: 5.191

5.  Targeting isoprenoid biosynthesis for drug discovery: bench to bedside.

Authors:  Eric Oldfield
Journal:  Acc Chem Res       Date:  2010-09-21       Impact factor: 22.384

6.  Amiodarone triggers induction of apoptosis in cutaneous leishmaniasis agents.

Authors:  Somayeh Bahrami; Shahram Khademvatan; Mohammad Hossein Razi Jalali; Sepide Pourbaram
Journal:  Pathog Glob Health       Date:  2016-08-24       Impact factor: 2.894

7.  Mechanism of Action of Miltefosine on Leishmania donovani Involves the Impairment of Acidocalcisome Function and the Activation of the Sphingosine-Dependent Plasma Membrane Ca2+ Channel.

Authors:  Andrea K Pinto-Martinez; Jessica Rodriguez-Durán; Xenon Serrano-Martin; Vanessa Hernandez-Rodriguez; Gustavo Benaim
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

8.  Inhibition of Leishmania mexicana Growth by the Tuberculosis Drug SQ109.

Authors:  Verónica García-García; Eric Oldfield; Gustavo Benaim
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

9.  Dronedarone, an amiodarone analog with improved anti-Leishmania mexicana efficacy.

Authors:  Gustavo Benaim; Paola Casanova; Vanessa Hernandez-Rodriguez; Sheira Mujica-Gonzalez; Nereida Parra-Gimenez; Lourdes Plaza-Rojas; Juan Luis Concepcion; Yi-Liang Liu; Eric Oldfield; Alberto Paniz-Mondolfi; Alirica I Suarez
Journal:  Antimicrob Agents Chemother       Date:  2014-02-03       Impact factor: 5.191

10.  Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs.

Authors:  Wanderley de Souza; Juliany Cola Fernandes Rodrigues
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.